Related Experiment Video
Updated: Aug 24, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor
Ben J Gu1, Ronald Sluyter, Kristen K Skarratt
1Department of Medicine, University of Sydney at Nepean Hospital, Penrith, New South Wales 2750, Australia.
Abstract:
The P2X(7) receptor is a ligand-gated channel that is highly expressed on mononuclear cells of the immune system and that mediates ATP-induced apoptosis. Wide variations in the function of the P2X receptor have been observed, explained in part by (7)loss-of-function polymorphisms that change Glu(496) to Ala (E496A) and Ile(568) to Asn (I568N). In this study, a third polymorphism, which substitutes an uncharged glutamine for the highly positively charged Arg(307) (R307Q), has been found in heterozygous dosage in 12 of 420 subjects studied. P2X(7) function was measured by ATP-induced fluxes of Rb(+), Ba(2+), and ethidium(+) into peripheral blood monocytes or various lymphocyte subsets and was either absent or markedly decreased. Transfection experiments showed that P2X(7) carrying the R307Q mutation lacked either channel or pore function despite robust protein synthesis and surface expression of the receptor. The monoclonal antibody (clone L4) that binds to the extracellular domain of wild type P2X(7) and blocks P2X(7) function failed to bind to the R307Q mutant receptor. Differentiation of monocytes to macrophages up-regulated P2X(7) function in cells heterozygous for the R307Q to a value 10-40% of that for wild type macrophages. However, macrophages from a subject who was double heterozygous for R307Q/I568N remained totally non-functional for P2X(7), and lymphocytes from the same subject also lacked ATP-stimulated phospholipase D activity. These data identify a third loss-of-function polymorphism affecting the human P2X(7) receptor, and since the affected Arg(307) is homologous to those amino acids essential for ATP binding to P2X(1) and P2X(2), it is likely that this polymorphism abolishes the binding of ATP to the extracellular domain of P2X(7).
Insights
A new P2X7 receptor polymorphism, R307Q, causes loss-of-function by preventing ATP binding. This discovery identifies a third common genetic variant impacting immune cell responses mediated by the P2X7 receptor.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- The P2X7 receptor (P2X7R) is a critical immune cell receptor involved in ATP-induced apoptosis.
- Known loss-of-function polymorphisms (E496A, I568N) partially explain variations in P2X7R function.
- Understanding P2X7R genetic variations is crucial for immune system research.
Purpose of the Study:
- To identify and characterize novel loss-of-function polymorphisms in the human P2X7 receptor.
- To investigate the functional consequences of a newly identified R307Q polymorphism on P2X7R activity.
- To determine the impact of this polymorphism on ATP binding and receptor function.
Main Methods:
- Genotyping of 420 subjects to identify P2X7R polymorphisms.
- Functional assays measuring ion fluxes (Rb+, Ba2+, ethidium+) in monocytes and lymphocytes.
- Transfection studies to assess P2X7R protein synthesis, surface expression, and function.
- Monoclonal antibody binding assays to evaluate receptor-ligand interactions.
Main Results:
- A novel heterozygous polymorphism, R307Q, was identified in 12 of 420 subjects.
- The R307Q mutation resulted in absent or markedly decreased P2X7R channel and pore function.
- R307Q P2X7R exhibited normal protein synthesis and surface expression but failed to bind a specific blocking antibody.
- Monocyte-to-macrophage differentiation partially restored function in heterozygous R307Q cells, but double heterozygotes (R307Q/I568N) showed complete loss-of-function.
Conclusions:
- The R307Q polymorphism represents a third significant loss-of-function variant of the human P2X7 receptor.
- This polymorphism likely abolishes ATP binding to the extracellular domain of P2X7R, impacting immune cell signaling.
- The findings contribute to understanding genetic variability in immune responses mediated by P2X7R.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
ATP Synthase: Mechanism
GPCR Desensitization
Ligand-Gated Ion Channel Receptor: Gating Mechanism
